Immunitor
Immunitor is a Mongolian biotech, founded in 2000, that makes oral tablet vaccines from heat-inactivated cells; its hepatocellular carcinoma vaccine hepcortespenlisimut-L went through phase 3 trials the company led.
Overview
Immunitor, based in Ulaanbaatar and founded in 2000, develops oral tablet immunotherapies made from heat-inactivated cells, including a tuberculosis vaccine and hepcortespenlisimut-L (V5) for hepatocellular carcinoma, which it tested in phase 3 trials in Mongolia registered on ClinicalTrials.gov under Immunitor as lead sponsor.
Similar pages
not linked directly; found by shared links- CompanyAscletis Pharma
Shares Pivotal (registrational) trial, Clinical trial, Hepatocellular carcinoma and the tag ctgov-sponsor.
- CompanyCan-Fite BioPharma
Shares Pivotal (registrational) trial, Clinical trial, Hepatocellular carcinoma and the tag ctgov-sponsor.
- CompanyGC Cell
Shares Pivotal (registrational) trial, Clinical trial, Hepatocellular carcinoma and the tag ctgov-sponsor.
- CompanyCSL Limited
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyD3 Bio (Wuxi)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyDong-A ST
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEndo (now Keenova Therapeutics and Par Health)
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.
- CompanyEurofarma
Shares Pivotal (registrational) trial, Clinical trial and the tag ctgov-sponsor.